ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2318

Increasing Rates of Remission in Juvenile Idiopathic Arthritis through a Quality Improvement Learning Network – the Pediatric Rheumatology Care and Outcomes Improvement Network

Esi M. Morgan DeWitt1, Stacy P. Ardoin2, C. April Bingham3, Beth S. Gottlieb4, Ronald Laxer5, Nancy Griffin6, Jesse Pratt7, Anne Paul8, Daniel Lovell9, Judyann C. Olson10, Murray H. Passo11, Jennifer E. Weiss12, Tzielan C. Lee13, Sheetal S. Vora14, Melissa M. Hazen15 and Peter Margolis16, 1Department of Pediatrics, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, 3Penn State Hershey Children's Hospital, Hershey, PA, 4Pediatric Rheumatology, Cohen Children's Medical Center of New York, New Hyde Park, NY, 5Rheumatology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 6James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, OH, 10Medical College of Wisconsin, Milwaukee, WI, 11Pediatric Rheumatology, Medical University of South Carolina, Charleston, SC, 12Pediatric Rheumatology, Joseph M Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack, NJ, 13Pediatric Rheumatology, Stanford University School of Medicine, Stanford, CA, 14University of North Carolina Chapel Hill, Chapel Hill, NC, 15Division of Immunology, Boston Children's Hospital, Boston, MA, 16Clinical Effectiveness, Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Chronic disease care, patient outcomes, Pediatric rheumatology, quality improvement and quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Quality Measures and Quality of Care

Session Type: Abstract Submissions (ACR)

Background/Purpose

The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) since 2011 has used quality improvement (QI) methods, chronic illness care model interventions, and a modified, sustainable, Breakthrough Series Collaborative approach to operations.  As the network matures in use of population management and pre-visit planning interventions measureable improvements in remission outcomes for children with juvenile idiopathic arthritis (JIA) are being realized.

Methods

Teams conduct Plan-Do-Study-Act cycles using the Model for Improvement. Sites contribute data to a shared registry.  Informed consent is obtained from patients for research uses.  Data is displayed in run charts, funnel charts, and Pareto charts.  Strategies for use of the Population Management Tool include peer review of patients with more than mild disease activity assessed by Physician Global Assessment >3 with decision support treatment algorithms.  Pre-visit planning increases reliability of completion of process measures of care (medication safety lab tests, uveitis eye screening) and flags patients for needed services such as PT, OT, or if there is inadequate disease control.  Patients are being engaged at network and local levels to inform priorities and contribute to improvement work.  Teams share resources, materials and best practices on monthly webinars, “Learning Labs”, and semi-annual face-to-face “learning sessions”. 

Results

8 of 11 participant sites submit data to the registry (ACR Rheumatology Clinical Registry). 1,457 patients contribute 7,040 encounters. Rates of clinical remission on medication for 6 months were statistically increased from baseline of 37.2% to 48.4% in the aggregate.   There is variability in current site performance by >20%, with remission rates for May 2014 ranging from 39.4% – 62.7% at individual sites. 

Conclusion

PR-COIN has marked a turning point from early improvement in process measures of care to demonstrable improvement in outcomes as teams are more experienced in QI methods and more reliably implementing pre-visit planning and using population management approaches.  Variability in site performance provides opportunity for shared best practices.  Challenges to growth have included delays in regulatory approval, and currently a single IRB model is being implemented.  Double data entry is a barrier to efficient participation and teams are jointly developing “SmartForms” for electronic health records to facilitate standardized data collection and electronic data transfer.  Patient engagement is a new direction expected to support enrollment and influence self-management initiatives.


Disclosure:

E. M. Morgan DeWitt,
None;

S. P. Ardoin,
None;

C. A. Bingham,
None;

B. S. Gottlieb,
None;

R. Laxer,
None;

N. Griffin,
None;

J. Pratt,
None;

A. Paul,
None;

D. Lovell,
None;

J. C. Olson,
None;

M. H. Passo,
None;

J. E. Weiss,
None;

T. C. Lee,
None;

S. S. Vora,
None;

M. M. Hazen,
None;

P. Margolis,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increasing-rates-of-remission-in-juvenile-idiopathic-arthritis-through-a-quality-improvement-learning-network-the-pediatric-rheumatology-care-and-outcomes-improvement-network/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology